Is There a Renaissance of Glucocorticoids in Rheumatoid Arthritis?

J R Kirwan, Wma Gunasekera

Research output: Contribution to journalArticle (Academic Journal)peer-review

3 Citations (Scopus)

Abstract

The first therapeutic use of glucocorticoids was in a patient with severe rheumatoid arthritis and the symptomatic benefit was astounding. Adverse effects from increasingly large doses led to them being overshadowed, dismissed as inappropriate treatment, and ignored for 20 years - but in the last 2 decades, the accumulating evidence and clinical practice suggest there is a justified renaissance in their use as a first-line treatment.

Original languageEnglish
JournalClinical Pharmacology and Therapeutics
DOIs
Publication statusPublished - 7 Aug 2017

Keywords

  • Journal Article

Fingerprint Dive into the research topics of 'Is There a Renaissance of Glucocorticoids in Rheumatoid Arthritis?'. Together they form a unique fingerprint.

Cite this